Adding a single analog insulin formulation to metformin and sulfonylurea resulted in current best practice targets of a glycated hemoglobin level of 6.5% or less in fewer than one quarter of patients at 1 year.

Among patients treated with statins, including those who achieved very low levels of cholesterol with high-dose statin therapy, HDL-cholesterol levels are still predictive of major cardiovascular events.

Vildagliptin monotherapy is effective and well tolerated in treatment-naive elderly patients with type 2 diabetes, according to an analysis from 5 trials.

Many patients with diabetes say that the inconvenience and discomfort of constant therapeutic vigilance, particularly multiple daily insulin injections, has as much impact on their quality of life as the burden of intermediate complications.

Poor glycemic control in diabetics is linked to an increased risk of cardiovascular events, a large retrospective study suggests.

In blood glucose responses to a white bread challenge, individual patients have significant variations from test to test and is too variable to be a useful measurement

A new study conducted on mice at the Salk Institute, reveals the potential for a drug that can give the same results as exercise. 

Insulin, it turns out, may be as important for the mind as it is for the body. Research in the last few years has raised the possibility that Alzheimer’s memory loss could be due to a novel third form of diabetes.

Some studies have hinted that cinnamon may aid blood sugar control, yet others show it is not beneficial for people with diabetes, according to researchers.

The International Diabetes Federation launches new guideline for the management of postmeal glucose.